Table of Contents

    Topic review

    DOCK8 Gene

    Subjects: Genetics
    View times: 3
    Submitted by: Vivi Li
    (This entry belongs to Entry Collection "MedlinePlus ")

    Definition

    Dedicator of Cytokinesis 8

    1. Normal Function

    The DOCK8 gene provides instructions for making a member of the DOCK family of proteins. The proteins in this family act as guanine nucleotide exchange factors (GEFs). GEFs turn on (activate) proteins called GTPases, which play an important role in chemical signaling within cells. Signaling stimulated by DOCK family proteins are typically involved in the arrangement of the structural framework inside cells (the cytoskeleton). By controlling the shape of the cytoskeleton, DOCK family proteins play a role in cell structure and movement (migration).

    The DOCK8 protein is found most abundantly in cells of the immune system. This protein plays a critical role in the survival and function of several types of immune system cells, including T cells, NK cells, and B cells. T cells and NK cells recognize and attack foreign invaders, such as viruses, to prevent infection. B cells produce proteins called antibodies, which attach to foreign particles and germs and mark them for destruction.

    Through its function as a GEF, the DOCK8 protein helps maintain the structure and integrity of T cells and NK cells. It also aids in the movement of these immune system cells to sites of infection, particularly the skin. The DOCK8 protein is also involved in chemical signaling pathways that stimulate B cells to mature and produce antibodies. The protein is also involved in the normal development and survival of other types of immune system cells.

    2. Health Conditions Related to Genetic Changes

    2.1 DOCK8 Immunodeficiency Syndrome

    More than 130 mutations in the DOCK8 gene have been found to cause DOCK8 immunodeficiency syndrome (also called autosomal recessive hyper-IgE syndrome or AR-HIES). DOCK8 immunodeficiency syndrome is an immune system disorder that causes recurrent severe infections of the skin and respiratory tract. Affected individuals may have other immune system problems, such as allergies, asthma, or an inflammatory skin disorder called eczema. Most of the mutations involved in DOCK8 immunodeficiency syndrome delete regions of DNA from the DOCK8 gene. These deletions and other DOCK8 gene mutations lead to production of an abnormally short protein or production of no protein. As a result, affected individuals have little or no functional DOCK8 protein.

    A shortage of DOCK8 protein impairs normal immune cell development and function. It is thought that T cells lacking DOCK8 protein cannot maintain their shape as they move through dense spaces, such as those found within the skin. The abnormal cells die too easily, resulting in reduced numbers of these cells. A shortage of T cells impairs the immune response to foreign invaders, accounting for the severe skin infections common in DOCK8 immunodeficiency syndrome. A lack of DOCK8 protein also impairs B cell maturation and the production of certain antibodies. Impairment of this type of immune response leads to recurrent respiratory tract infections in people with this disorder.

    For unknown reasons, a reduction of DOCK8 protein results in higher-than-normal production of an immune system protein known as immunoglobulin E (IgE), which plays a role in allergic reactions. As a result, people with DOCK8 immunodeficiency syndrome have an increased risk of food and environmental allergies.

    3. Other Names for This Gene

    • 1200017A24Rik

    • dedicator of cytokinesis protein 8 isoform 1

    • dedicator of cytokinesis protein 8 isoform 2

    • dedicator of cytokinesis protein 8 isoform 3

    • epididymis luminal protein 205

    • FLJ00026

    • FLJ00152

    • FLJ00346

    • HEL-205

    • MRD2

    • ZIR8

    The entry is from https://medlineplus.gov/genetics/gene/dock8

    References

    1. Crawford G, Enders A, Gileadi U, Stankovic S, Zhang Q, Lambe T, Crockford TL, Lockstone HE, Freeman A, Arkwright PD, Smart JM, Ma CS, Tangye SG, Goodnow CC,Cerundolo V, Godfrey DI, Su HC, Randall KL, Cornall RJ. DOCK8 is critical for thesurvival and function of NKT cells. Blood. 2013 Sep 19;122(12):2052-61. doi:10.1182/blood-2013-02-482331.
    2. Engelhardt KR, McGhee S, Winkler S, Sassi A, Woellner C, Lopez-Herrera G, ChenA, Kim HS, Lloret MG, Schulze I, Ehl S, Thiel J, Pfeifer D, Veelken H, Niehues T,Siepermann K, Weinspach S, Reisli I, Keles S, Genel F, Kutukculer N, Camcioğlu Y,Somer A, Karakoc-Aydiner E, Barlan I, Gennery A, Metin A, Degerliyurt A,Pietrogrande MC, Yeganeh M, Baz Z, Al-Tamemi S, Klein C, Puck JM, Holland SM,McCabe ER, Grimbacher B, Chatila TA. Large deletions and point mutationsinvolving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol. 2009 Dec;124(6):1289-302.e4. doi: 10.1016/j.jaci.2009.10.038. Erratum in: J Allergy Clin Immunol. 2010Mar;125(3):743. Kutuculer, Necil [corrected to Kutukculer, Necil].
    3. Harada Y, Tanaka Y, Terasawa M, Pieczyk M, Habiro K, Katakai T,Hanawa-Suetsugu K, Kukimoto-Niino M, Nishizaki T, Shirouzu M, Duan X, Uruno T,Nishikimi A, Sanematsu F, Yokoyama S, Stein JV, Kinashi T, Fukui Y. DOCK8 is aCdc42 activator critical for interstitial dendritic cell migration during immune responses. Blood. 2012 May 10;119(19):4451-61. doi: 10.1182/blood-2012-01-407098.
    4. Jabara HH, McDonald DR, Janssen E, Massaad MJ, Ramesh N, Borzutzky A, RauterI, Benson H, Schneider L, Baxi S, Recher M, Notarangelo LD, Wakim R, Dbaibo G,Dasouki M, Al-Herz W, Barlan I, Baris S, Kutukculer N, Ochs HD, Plebani A,Kanariou M, Lefranc G, Reisli I, Fitzgerald KA, Golenbock D, Manis J, Keles S,Ceja R, Chatila TA, Geha RS. DOCK8 functions as an adaptor that links TLR-MyD88signaling to B cell activation. Nat Immunol. 2012 May 13;13(6):612-20. doi:10.1038/ni.2305.
    5. Lambe T, Crawford G, Johnson AL, Crockford TL, Bouriez-Jones T, Smyth AM, PhamTH, Zhang Q, Freeman AF, Cyster JG, Su HC, Cornall RJ. DOCK8 is essential forT-cell survival and the maintenance of CD8+ T-cell memory. Eur J Immunol. 2011Dec;41(12):3423-35. doi: 10.1002/eji.201141759.
    6. Randall KL, Lambe T, Johnson AL, Treanor B, Kucharska E, Domaschenz H, WhittleB, Tze LE, Enders A, Crockford TL, Bouriez-Jones T, Alston D, Cyster JG, Lenardo MJ, Mackay F, Deenick EK, Tangye SG, Chan TD, Camidge T, Brink R, Vinuesa CG,Batista FD, Cornall RJ, Goodnow CC. Dock8 mutations cripple B cell immunological synapses, germinal centers and long-lived antibody production. Nat Immunol. 2009 Dec;10(12):1283-91. doi: 10.1038/ni.1820.Immunol. 2010 Jul;11(7):644. Johnson, Andy [corrected to Johnson, Andy L].
    7. Su HC, Jing H, Angelus P, Freeman AF. Insights into immunity from clinical andbasic science studies of DOCK8 immunodeficiency syndrome. Immunol Rev. 2019Jan;287(1):9-19. doi: 10.1111/imr.12723. Review.
    8. Zhang Q, Dove CG, Hor JL, Murdock HM, Strauss-Albee DM, Garcia JA, Mandl JN,Grodick RA, Jing H, Chandler-Brown DB, Lenardo TE, Crawford G, Matthews HF,Freeman AF, Cornall RJ, Germain RN, Mueller SN, Su HC. DOCK8 regulates lymphocyteshape integrity for skin antiviral immunity. J Exp Med. 2014 Dec15;211(13):2549-66. doi: 10.1084/jem.20141307.
    9. Zhang Q, Jing H, Su HC. Recent Advances in DOCK8 Immunodeficiency Syndrome. J Clin Immunol. 2016 Jul;36(5):441-9. doi: 10.1007/s10875-016-0296-z.
    More

    Keywords